Thursday, February 27, 2025
spot_img

IDEX Biometrics interim report for the fourth quarter and preliminary result for 2024

Oslo, Norway: IDEX Biometrics ASA’s interim report for the fourth quarter and preliminary result 2024 is attached to this notice, including the fourth quarter 2024 presentation.

The report and presentation are available on the IDEX Biometrics website:

www.idexbiometrics.com/investors


Recent highlights 

  • Certification of IDEX PAY platform allowing manufacturers to certify and launch Biometric Payment Card programs with both Visa and Mastercard globally.
  • Reaching scale manufacturing quality among key partners, enabling them and us to go beyond pilot volumes.
  • IDEX Biometrics partner KONA I becomes first manufacturer certified by Mastercard for both PVC and metal biometric cards.
  • Access: Received an order from DigAware to deliver a biometric sensor solution to enhance their smart badges. DigAware’s new biometric ID badge incorporates RFID radios for emergency situations in environments such as schools, hospitals, and enterprises.
  • Payments: First commercial launch in Japan together with Life Card, subsidiary to AIFUL Japan’s third largest consumer finance company. Life Card’s commercial roll-out is targeted for the first half of 2025.
  • Streamlined global operations and progressed on cost efficiencies, aligning resources with key market priorities and further optimized our workforce.
  • Completed rights issue in November, allowing retail investors to participate at the same terms as shareholders participating in the September capital raise.


Financial results Q4 2024

  • No product revenues in the fourth quarter.
  • Operating expenses excluding cost of products sold and bad debt provisions amounted to $2.4 million in the fourth quarter, below target at $2.5 million.
  • An accrual for loss on receivables from Zwipe AS amounting to $0.6 million has been included in the fourth quarter of 2024.
  • Net loss in the fourth quarter of 2024 was $2.1 million. The result includes net financial gain amounting to $2.4 million caused by value change of warrants and the derivative related to the convertible debt. Adjusted for these items, the result would have been a net loss of $4.6 million.
  • A non-cash impairment of goodwill amounting to $968 thousand was recorded in the fourth quarter.
  • Cash balance per 31 December 2024 at $2.0 million

 

For further information contact: 
Marianne Bøe, Head of Investor Relations, +47 91800186
Kristian Flaten, CFO + 47 95092322
E-mail: [email protected]

 

About IDEX Biometrics 

IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com)

 

Trademark Statement

IDEX, TrustedBio, IDEX Biometrics and the IDEX logo are trademarks owned by IDEX Biometrics ASA. All other brands or product names are the property of their respective holders.

 

About this notice

This notice was issued by Marianne Bøe, Head of Investor Relations, on 27 February 2025 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 5‑6 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5‑12 of the STA.

Attachments

  • IDEX BIOMETRICS Q4 2024 REPORT
  • IDEX BIOMETRICS Q4 2024 PRESENTATION

Powered by SlickText.com

Hot this week

SJW Group Announces Leadership Transition and Executive Promotions to Drive Continued Growth

Eric W. Thornburg to retire as Chief Executive Officer...

No. 4/2025 – Managers transactions

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K   ...

Topics

No. 4/2025 – Managers transactions

Nasdaq Copenhagen                                                                                    Nikolaj Plads 6 DK-1067 Copenhagen K   ...

Spineway marks its return to Arab Health 2025 with new distribution agreements

Press release         Ecully, February 27, 2025 – 6.30...

Transaction in Own Shares

Transaction in Own Shares 27 February, 2025 ...

Vantiva – Full Year 2024 Estimated Operational Results

Press Release Estimated Operational Results 2024 Vantiva...
spot_img

Related Articles

Popular Categories

spot_img